BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37459124)

  • 1. Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease.
    Rabinovici GD; La Joie R
    JAMA; 2023 Aug; 330(6):507-509. PubMed ID: 37459124
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines: chasing the dream.
    Schnabel J
    Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
    [No Abstract]   [Full Text] [Related]  

  • 3. J&J's billion dollar punt on anti-amyloid antibody.
    Sheridan C
    Nat Biotechnol; 2009 Aug; 27(8):679-81. PubMed ID: 19668155
    [No Abstract]   [Full Text] [Related]  

  • 4. CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease.
    Knopman D; Sano M; Feldman HH
    Nat Rev Neurol; 2022 Jul; 18(7):379-380. PubMed ID: 35596071
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer disease: Lessons from immunotherapy for Alzheimer disease.
    Wang YJ
    Nat Rev Neurol; 2014 Apr; 10(4):188-9. PubMed ID: 24638135
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amyloid-beta protein vaccine therapy for alzheimer's disease].
    Hara H
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1122-8. PubMed ID: 16846064
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease.
    Grundke-Iqbal I; Iqbal K; George L; Tung YC; Kim KS; Wisniewski HM
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2853-7. PubMed ID: 2649895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy.
    Greenberg SM; Frosch MP
    Neurology; 2011 Mar; 76(9):772-3. PubMed ID: 21357829
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.
    Allsop D; Wong CW; Ikeda S; Landon M; Kidd M; Glenner GG
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2790-4. PubMed ID: 3282239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.
    Sambamurti K; Pappolla MA; Jagannatha Rao KS
    J Alzheimers Dis; 2008 Jun; 14(2):175-7. PubMed ID: 18663823
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyloid-beta immunotherapy: the hope for Alzheimer disease?
    Barrera-Ocampo A; Lopera F
    Colomb Med (Cali); 2016 Dec; 47(4):203-212. PubMed ID: 28293044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.
    van Dyck CH
    Biol Psychiatry; 2018 Feb; 83(4):311-319. PubMed ID: 28967385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.].
    Araki S
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):21-5. PubMed ID: 20628209
    [No Abstract]   [Full Text] [Related]  

  • 14. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching NeuroImage: Severe Amyloid-Related Imaging Abnormalities After Anti-β-Amyloid Monoclonal Antibody Treatment.
    Bonomi S; Samara A; Balestra N; Padalia A; Benzinger TL; Kang P
    Neurology; 2023 Dec; 101(23):1079-1080. PubMed ID: 37816643
    [No Abstract]   [Full Text] [Related]  

  • 16. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 17. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
    Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
    Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in anti-beta antibody treatment of Alzheimer's disease].
    Zhang JH; Liang P
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):633-5. PubMed ID: 18070457
    [No Abstract]   [Full Text] [Related]  

  • 19. The amyloid hypothesis revisited: are monoclonal antibodies truly effective?
    Ross J; Hasan I
    Inflammopharmacology; 2023 Jun; 31(3):1027-1028. PubMed ID: 36995576
    [No Abstract]   [Full Text] [Related]  

  • 20. Amyloid Cascade into Clarity.
    Weitz TM; Town T
    Immunity; 2016 Oct; 45(4):717-718. PubMed ID: 27760336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.